Domov › Chronická lymfocytová leukémia › North Carolina › Durham
Klinické štúdie Chronická lymfocytová leukémia v meste Durham, NC
27 štúdií pre Chronická lymfocytová leukémia hľadá účastníkov v zariadeniach v meste Durham a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Prebieha náborFáza 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Durham VA Medical Center, Durham
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Prebieha náborFáza 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 míľ odtiaľ
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Prebieha náborFáza 3
- Duke University Medical Center, Durham
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Prebieha náborFáza 3
- University of North Carolina At Chapel Hill, Chapel Hill · 10 míľ odtiaľ
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Prebieha náborFáza 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 10 míľ odtiaľ
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Prebieha náborFáza 3
- Duke University, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Prebieha náborFáza 2
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
Prebieha náborFáza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Prebieha náborFáza 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 míľ odtiaľ
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
Prebieha náborFáza 2
- Research Site, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Prebieha náborFáza 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 míľ odtiaľ
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Prebieha náborFáza 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 míľ odtiaľ
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Prebieha náborFáza 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Prebieha nábor
- North Carolina Basnight Cancer Hospital, Chapel Hill · 10 míľ odtiaľ
Registry of Older Patients With Cancer
Prebieha náborObservačná štúdia
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 míľ odtiaľ
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Prebieha náborFáza 1
- University of North Carolina, Chapel Hill · 10 míľ odtiaľ
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Prebieha náborFáza 4
- Duke University Medical Center, Durham
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Prebieha náborFáza 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
Prebieha náborFáza 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Prebieha náborFáza 2
- University of North Carolina /ID# 233313, Chapel Hill · 10 míľ odtiaľ
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Prebieha náborFáza 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 míľ odtiaľ
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Prebieha náborFáza 1
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Prebieha náborObservačná štúdia
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 míľ odtiaľ
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Prebieha náborFáza 2
- Durham VA Medical Center, Durham, NC, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Prebieha náborFáza 1
- University of North Carolina, Chapel Hill · 10 míľ odtiaľ
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Prebieha náborFáza 1
- Duke University, Durham
Štúdie Chronická lymfocytová leukémia v iných mestách
- Boston, MA31 štúdií
- Columbus, OH28 štúdií
- Washington, DC22 štúdií
- Seattle, WA20 štúdií
- Rochester, MN18 štúdií
- New York City, NY18 štúdií
- Houston, TX17 štúdií
- Baldwin Park, CA16 štúdií
- Milwaukee, WI15 štúdií
- Chicago, IL14 štúdií
- Cincinnati, OH14 štúdií
- Nashville, TN13 štúdií
Iné štúdie v Durham
- Rakovina prsníka64 štúdií
- Rakovina (všetky typy)58 štúdií
- Nemalobunkový karcinóm pľúc39 štúdií
- Mnohonásobný myelóm37 štúdií
- Akútna myeloidná leukémia33 štúdií
- Metastatická rakovina33 štúdií
- Rakovina prostaty32 štúdií
- Rakovina pľúc32 štúdií
- Kolorektálny karcinóm28 štúdií
- Rakovina vaječníkov27 štúdií
- Srdcové zlyhanie26 štúdií
- Rakovina pankreasu24 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.